doi:10.3969/j.issn.1673-8640.2025.06.014

Abstract

CLC Number:

R446.1

Figures/Tables 5

References 7

[1]	中国医学装备协会检验医学分会, 中华医学会检验医学分会. 即时检测(POCT)临床结果报告与发布中国专家共识[J]. 中华检验医学杂志, 2020, 43(5):567-569.
[2]	陈宇欣, 张国军. POCT在慢病管理中的应用价值与存在的问题[EB/OL].(2022-12-03)[2024-05-16]. https://www.ivdchina.org/cclabd/show-1784.html.
[3]	SHAW J L V, ARNOLDO S, BEACH L, et al. Establishing quality indicators for point of care glucose testing:recommendations from the canadian society for clinical chemists point of care testing and quality indicators special interest groups[J]. Clin Chem Lab Med, 2023, 61(7):1280-1287.
[4]	中华人民共和国国家卫生健康委员会. WS/T 781—2021 便携式血糖仪临床操作和质量管理指南[S]. 北京: 中华人民共和国国家卫生健康委员会, 2021.
[5]	乔莉, 朱越石, 陈妍, 等. 基于信息化质控平台对某三甲医院住院患者POCT血糖管理的现状调查[J]. 江苏卫生事业管理, 2023, 34(2):194-198.
[6]	田雨鑫, 闫立昌, 宗晓龙, 等. POCT血糖仪及全自动生化分析仪血糖检测结果对比研究[J]. 中国医疗器械信息, 2021, 27(18):7-8.
[7]	阮帅, 陈保德, 金建敏, 等. 多院区POCT同质化管理模式[J]. 检验医学与临床, 2024, 21(4):572-576.

仪器类型	总符合率	血糖<5.5 mmol·L^-1符合率	血糖≥5.5 mmol·L^-1符合率
品牌A	98（192/195）	100（51/51）	98（141/144）
品牌B	100（155/155）	100（62/62）	100（93/93）

仪器类型	总符合率	血糖<5.5 mmol·L^-1符合率	血糖≥5.5 mmol·L^-1符合率
品牌A	98（192/195）	100（51/51）	98（141/144）
品牌B	100（155/155）	100（62/62）	100（93/93）

样本	全自动生化分析仪	品牌A	t值	P值
1	12.36±0.11	12.60±0.12	0.759	0.477
2	2.03±0.09	2.04±0.09	0.255	0.807
3	4.55±0.10	4.66±0.09	0.548	0.604
4	6.53±0.11	6.46±0.19	-1.033	0.342
5	20.47±0.22	20.44±0.23	-0.311	0.766

样本	全自动生化分析仪	品牌A	t值	P值
1	12.36±0.11	12.60±0.12	0.759	0.477
2	2.03±0.09	2.04±0.09	0.255	0.807
3	4.55±0.10	4.66±0.09	0.548	0.604
4	6.53±0.11	6.46±0.19	-1.033	0.342
5	20.47±0.22	20.44±0.23	-0.311	0.766

样本	全自动生化分析仪	品牌B	t值	P值
1	15.00±0.49	15.12±0.73	2.086	0.082
2	9.04±0.23	9.08±0.35	-0.794	0.458
3	6.54±0.28	6.64±0.26	1.969	0.096
4	5.14±0.19	5.26±0.24	-0.468	0.656
5	2.38±0.11	2.34±0.15	-1.758	0.129

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 7

Related Articles 15

Recommended Articles

Metrics

样本	2021年					2022年					2023年
样本	检验科	骨科	心血管科	肾病科	针灸科	检验科	骨科	心血管科	肾病科	针灸科	检验科	骨科	心血管科	肾病科	针灸科
1	1.60	1.06	1.06	2.13	1.60	-5.55	-4.83	-5.55	-6.99	-4.11	5.70	-10.99	-10.99	-1.25	-12.38
2	-0.15	1.32	-0.15	1.32	-0.15	3.99	1.36	3.99	1.80	2.24	-2.83	-7.42	-1.30	-7.42	0.23
3	-0.61	0.15	0.15	0.15	0.15	-0.71	2.33	-0.71	-6.79	-5.78	3.07	1.18	-1.65	2.13	-0.24
4	1.89	1.43	1.43	1.89	1.89	-3.77	2.07	-3.77	-4.84	-3.77	-3.43	-2.36	-7.73	-2.36	-1.29
5	-0.64	-0.64	-0.64	-0.64	-0.64	-6.44	-1.84	-1.84	-0.31	-3.37	-1.31	-6.22	-4.03	0.87	-5.67

[1]	. [J]. Laboratory Medicine, 2025, 40(6): 601-605.
[2]	MA Jingyun, WANG Mengmeng, XIONG Boyu, DAI Zhuowen, PAN Yueyue, WANG Qiong. Research progress in phenotypic characteristics and treatment efficacy evaluation of acute promyelocytic leukemia variants [J]. Laboratory Medicine, 2025, 40(6): 606-614.
[3]	CAO Shuxian, GAO Yinan, SONG Yufan, LU Sumei. Research progress of lipid peroxidation in dysregulation of glucose and lipid metabolism [J]. Laboratory Medicine, 2025, 40(6): 615-620.
[4]	. [J]. Laboratory Medicine, 2025, 40(6): 621-624.
[5]	GUO Jingjing, LI Haixia, MA Qian, HUANG Haiming, ZENG Ziyi, AN Chongwen, PANG Lu. A retrospective analysis of serum 25（OH）D levels and related factors in a physical examination population in a Grade 3 Class A hospital in Beijing [J]. Laboratory Medicine, 2025, 40(6): 545-550.
[6]	YANG Qi, LIN Ying, GUO Nan, LI Xiaobin, SHANG E, LI Hongmin, YAO Xingwei. Changes of coagulation function in elderly patients with severe pneumonia infected by different Gram-negative bacteria [J]. Laboratory Medicine, 2025, 40(6): 560-564.
[7]	GONG Xiaolin, DENG Kun, WU Jun, REN Chuanli, XU Songxiao, LI Shengjie, LI Bo, YANG Dagan, SHEN Han, ZHANG Yi, CHEN Ming, WU Yongkang, LUO Huaichao, YUAN Xu, XU Huaguo, GONG Qian, LI Xin, GUAN Ming. AI technology reshaping laboratory medicine from automation to intelligent decision-making [J]. Laboratory Medicine, 2025, 40(5): 413-420.
[8]	WU Yazhou, LI Hanhua, MENG Leijun, CHEN Xuefei, SUN Yuhan, WENG Wenhao, ZHENG Bing. Fusobacterium nucleatum promoting chemoresistance of colorectal cancer cells via lncRNA XIST [J]. Laboratory Medicine, 2025, 40(5): 428-436.
[9]	CHEN Qun, LUO Qizhi, LIANG Hongmei, WU Yuanru, HE Dahui, LIAO Guoqiang, LIN Liyun, LU Xiaojing, YANG Dandan. Change and role of glycolipid metabolism markers in patients with benign prostatic hyperplasia [J]. Laboratory Medicine, 2025, 40(5): 443-449.
[10]	LI Yazhou, SU Min, ZHANG Jinghao, FANG Yi, WANG Su, WANG Shiwen, ZHAO Hu. Roles of single and combined determinations of CRP，HBP，CLR and HAR in the diagnosis of bloodstream infection in elderly patients [J]. Laboratory Medicine, 2025, 40(5): 489-492.
[11]	XU Dandan. Role of lactic acid/albumin ratio in short-term and long-term prognosis evaluation of ventilation therapy in AECOPD patients [J]. Laboratory Medicine, 2025, 40(5): 493-498.
[12]	YAO Lifeng, ZHANG Ling. Research progress on clinical significance of monocyte distribution width in infection and inflammatory diseases [J]. Laboratory Medicine, 2025, 40(5): 503-507.
[13]	ZHENG Yong, LÜ Lei, HE Kai. Clinical roles of serum GDF15 and YKL-40 in elderly patients with gallbladder cancer [J]. Laboratory Medicine, 2025, 40(4): 377-382.
[14]	GUI Jing, WANG Feng, CAI Yumao, HONG Chuangyue, YANG Hui. Correlation between oxidized high-density lipoprotein and comorbidity of T2DM and PTB [J]. Laboratory Medicine, 2025, 40(4): 350-357.
[15]	CHEN Weilong, WANG Yongbing, CHEN Zegang. Correlation between ZBED3，CYFRA21-1，VEGF and short-term mortality risk in patients with advanced liver cancer [J]. Laboratory Medicine, 2025, 40(4): 338-343.